What is Regeneron Pharmaceuticals's current operating income?

The latest figure on the record is $2.05 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $3.58 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026.

What was Regeneron Pharmaceuticals's operating income for the quarter ended September 30, 2026?

$2.05 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95).

When did Regeneron Pharmaceuticals's operating income last change?

The latest value on the record is $3.58 billion, dated December 31, 2025; before it the record holds $3.99 billion, dated December 31, 2024 and closed on December 31, 2025.

What was Regeneron Pharmaceuticals's operating income before $3.58 billion?

$3.99 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov).

organization · fact

Regeneron Pharmaceuticals operating income

As of November 9, 2026, the latest operating income figure on the AsOf record for Regeneron Pharmaceuticals is $2.05 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Regeneron Pharmaceuticals's latest full-year operating income is $3.58 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared.

latest operating income: $2.05 billionthe quarter ended September 30, 2026 · 1 source
full-year operating income: $3.58 billionDecember 31, 2025 · 1 source

18 dated values, oldest first; the current one in colour. In United States dollar.

Every dated value

18 values · 1 current · supersededA later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.More in About →

Regeneron Pharmaceuticals operating income: every dated value on the record, oldest first, with its dates, status, confidence and sources
value	valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →	valid to	confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →	sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →
-$86.25 million: operating income -86,249,000 United States dollar from 2008-12-31, claim clm_3E8FF1B94F70 and its sources (superseded) to 2009-12-31 · sec.gov	2008-12-31	2009-12-31	0.95	sec.gov
-$74.1 million: operating income -74,103,000 United States dollar from 2009-12-31, claim clm_C6F910B9B23D and its sources (superseded) to 2010-12-31 · sec.gov	2009-12-31	2010-12-31	0.95	sec.gov
-$97.47 million: operating income -97,472,000 United States dollar from 2010-12-31, claim clm_244D0F6FC089 and its sources (superseded) to 2011-12-31 · sec.gov	2010-12-31	2011-12-31	0.95	sec.gov
-$205.16 million: operating income -205,159,000 United States dollar from 2011-12-31, claim clm_E89A362E23D2 and its sources (superseded) to 2012-12-31 · sec.gov	2011-12-31	2012-12-31	0.95	sec.gov
$457.71 million: operating income 457,713,000 United States dollar from 2012-12-31, claim clm_38E3B92F967E and its sources (superseded) to 2013-12-31 · sec.gov	2012-12-31	2013-12-31	0.95	sec.gov
$760.03 million: operating income 760,028,000 United States dollar from 2013-12-31, claim clm_8A99CD2AC1DF and its sources (superseded) to 2014-12-31 · sec.gov	2013-12-31	2014-12-31	0.95	sec.gov
$838.43 million: operating income 838,431,000 United States dollar from 2014-12-31, claim clm_BFC64F70A0E6 and its sources (superseded) to 2015-12-31 · sec.gov	2014-12-31	2015-12-31	0.95	sec.gov
$1.25 billion: operating income 1,251,916,000 United States dollar from 2015-12-31, claim clm_83526134FED4 and its sources (superseded) to 2016-12-31 · sec.gov	2015-12-31	2016-12-31	0.95	sec.gov
$1.33 billion: operating income 1,330,741,000 United States dollar from 2016-12-31, claim clm_1B4689E225C8 and its sources (superseded) to 2017-12-31 · sec.gov	2016-12-31	2017-12-31	0.95	sec.gov
$2.08 billion: operating income 2,079,591,000 United States dollar from 2017-12-31, claim clm_C3B4B1FC7983 and its sources (superseded) to 2018-12-31 · sec.gov	2017-12-31	2018-12-31	0.95	sec.gov
$2.53 billion: operating income 2,534,400,000 United States dollar from 2018-12-31, claim clm_B9BD4A691253 and its sources (superseded) to 2019-12-31 · sec.gov	2018-12-31	2019-12-31	0.95	sec.gov
$2.21 billion: operating income 2,209,800,000 United States dollar from 2019-12-31, claim clm_1E47F3A48E8B and its sources (superseded) to 2020-12-31 · sec.gov	2019-12-31	2020-12-31	0.95	sec.gov
$3.58 billion: operating income 3,576,600,000 United States dollar from 2020-12-31, claim clm_B1B09D53441E and its sources (superseded) to 2021-12-31 · sec.gov	2020-12-31	2021-12-31	0.95	sec.gov
$8.95 billion: operating income 8,946,800,000 United States dollar from 2021-12-31, claim clm_C2D9EB28F08E and its sources (superseded) to 2022-12-31 · sec.gov	2021-12-31	2022-12-31	0.95	sec.gov
$4.74 billion: operating income 4,738,900,000 United States dollar from 2022-12-31, claim clm_1DC3E40C4DC4 and its sources (superseded) to 2023-12-31 · sec.gov	2022-12-31	2023-12-31	0.95	sec.gov
$4.05 billion: operating income 4,047,100,000 United States dollar from 2023-12-31, claim clm_5B0035249BB7 and its sources (superseded) to 2024-12-31 · sec.gov	2023-12-31	2024-12-31	0.95	sec.gov
$3.99 billion: operating income 3,990,700,000 United States dollar from 2024-12-31, claim clm_398CD3D76930 and its sources (superseded) to 2025-12-31 · sec.gov	2024-12-31	2025-12-31	0.95	sec.gov
$3.58 billion: operating income 3,577,900,000 United States dollar from 2025-12-31, claim clm_1B456AFB0CC5 and its sources to present · sec.gov	2025-12-31	present	0.95	sec.gov

What replaced what

17 replacements

-$86.25 million2008-12-31 to 2009-12-31→-$74.1 millionfrom 2009-12-31
-$74.1 million2009-12-31 to 2010-12-31→-$97.47 millionfrom 2010-12-31
-$97.47 million2010-12-31 to 2011-12-31→-$205.16 millionfrom 2011-12-31
-$205.16 million2011-12-31 to 2012-12-31→$457.71 millionfrom 2012-12-31
$457.71 million2012-12-31 to 2013-12-31→$760.03 millionfrom 2013-12-31
$760.03 million2013-12-31 to 2014-12-31→$838.43 millionfrom 2014-12-31
$838.43 million2014-12-31 to 2015-12-31→$1.25 billionfrom 2015-12-31
$1.25 billion2015-12-31 to 2016-12-31→$1.33 billionfrom 2016-12-31
$1.33 billion2016-12-31 to 2017-12-31→$2.08 billionfrom 2017-12-31
$2.08 billion2017-12-31 to 2018-12-31→$2.53 billionfrom 2018-12-31
$2.53 billion2018-12-31 to 2019-12-31→$2.21 billionfrom 2019-12-31
$2.21 billion2019-12-31 to 2020-12-31→$3.58 billionfrom 2020-12-31
$3.58 billion2020-12-31 to 2021-12-31→$8.95 billionfrom 2021-12-31
$8.95 billion2021-12-31 to 2022-12-31→$4.74 billionfrom 2022-12-31
$4.74 billion2022-12-31 to 2023-12-31→$4.05 billionfrom 2023-12-31
$4.05 billion2023-12-31 to 2024-12-31→$3.99 billionfrom 2024-12-31
$3.99 billion2024-12-31 to 2025-12-31→$3.58 billionfrom 2025-12-31

Questions this record answers

What is Regeneron Pharmaceuticals's current operating income?: The latest figure on the record is $2.05 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $3.58 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026.
What was Regeneron Pharmaceuticals's operating income for the quarter ended September 30, 2026?: $2.05 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95).
When did Regeneron Pharmaceuticals's operating income last change?: The latest value on the record is $3.58 billion, dated December 31, 2025; before it the record holds $3.99 billion, dated December 31, 2024 and closed on December 31, 2025.
What was Regeneron Pharmaceuticals's operating income before $3.58 billion?: $3.99 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov).

Answered from the rows above, as of November 9, 2026.

Cite Regeneron Pharmaceuticals operating income

Each form names the value, its as-of date (2026-09-30), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text

AsOf. "Regeneron Pharmaceuticals quarterly operating income: 2,048,200,000 United States dollar", as of 2026-09-30. Claim clm_4585DB96888D, https://asof.is/claim/clm_4585DB96888D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm.

APA

AsOf. (2026). Regeneron Pharmaceuticals quarterly operating income: 2,048,200,000 United States dollar (as of 2026-09-30) [Record clm_4585DB96888D]. Retrieved November 9, 2026, from https://asof.is/claim/clm_4585DB96888D (source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm)

BibTeX

@misc{asof_clm_4585DB96888D,
  author = {AsOf},
  title = {Regeneron Pharmaceuticals quarterly operating income: 2,048,200,000 United States dollar},
  year = {2026},
  howpublished = {\url{https://asof.is/claim/clm_4585DB96888D}},
  note = {Claim clm\_4585DB96888D, as of 2026-09-30; source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm},
  urldate = {2026-11-09}
}

Read on

/record/regeneron-pharmaceuticals/operating_income.md · this page as markdown
/record/regeneron-pharmaceuticals · /timelines/regeneron-pharmaceuticals

Other facts about Regeneron Pharmaceuticals

Record